Deutsche Bank appoints five bankers to prime finance business

Deutsche Bank Securities has appointed five senior bankers to its New York prime brokerage business.

Anthony Demonte has joined as a director in securities lending and will report to Paul Busby and Keith Babbitt, co-heads of securities lending in North America. Demonte joined from Lehman Brothers, where he spent nine years in the capital markets prime services group, most recently as senior vice-president.

Tom Filipovits has been appointed director in the client management group. He previously worked at Morgan Stanley’s client solutions group and at Goldman Sachs as product development manager. Filipovits will report to Timothy Lennon, head of client management in the US.

Keith Weintraub will join as a director in risk management, reporting to Satish Ramakrishna, head of risk for the global prime finance division. Weintraub joins the bank from Citigroup where he was director and head of development for the securitisation group. Before joining Citigroup, Weintraub was a quantitative risk manager at Archeus Capital Management. He spent 17 years at Citigroup in various roles within risk and analytics.

EJ Liotta will join as a director in the product development group, reporting to Mike Ginelli, global head of product development. Liotta previously worked at Merrill Lynch as a director responsible for prime brokerage technology, and at Barclays Capital in the equity finance and prime brokerage group.

John Dewey will join as a director in product management, where he will report to Jeff Dorman, head of global prime finance for North America and Chris East, director. Dewey joins from Lehman Brothers, where he has worked for the past six years in the capital markets prime services group.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here